Tofflon Plans India Subsidiary

CFW View: Strategic partnerships between China and India will bring reciprocal benefits, strengthening the pharmaceutical industry in both countries. However, manufacturing quality control will still remain as an issue, discouraging global consumers from purchasing Chinese- or Indian-made pharmaceuticals.

To read the full article, please choose one of the following options: